Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Garnl3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GARNL3 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GARNL3 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GARNL3 mRNA | CTD | PMID:31614463 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GARNL3 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Garnl3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GARNL3 mRNA | CTD | PMID:21570461 | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of GARNL3 mRNA | CTD | PMID:28522335 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GARNL3 mRNA | CTD | PMID:36041667 | acrolein | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GARNL3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GARNL3 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases methylation | ISO | GARNL3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GARNL3 gene and Aflatoxin B1 results in increased methylation of GARNL3 intron | CTD | PMID:27153756 and PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GARNL3 mRNA | CTD | PMID:33167477 | alpha-pinene | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GARNL3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GARNL3 mRNA | CTD | PMID:32699268 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of GARNL3 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of GARNL3 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of GARNL3 mRNA | CTD | PMID:33212167 | arsenous acid | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GARNL3 mRNA | CTD | PMID:20458559 | atrazine | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of GARNL3 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases methylation | ISO | Garnl3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of GARNL3 3' UTR and Benzo(a)pyrene results in increased methylation of GARNL3 exon | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GARNL3 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GARNL3 mRNA | CTD | PMID:36041667 | bisphenol A | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GARNL3 gene | CTD | PMID:31601247 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GARNL3 mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GARNL3 mRNA | CTD | PMID:36041667 | caffeine | increases phosphorylation | ISO | GARNL3 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of GARNL3 protein | CTD | PMID:35688186 | carmustine | affects response to substance | ISO | GARNL3 (Homo sapiens) | 6480464 | GARNL3 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | chlorpyrifos | increases expression | ISO | Garnl3 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of GARNL3 mRNA | CTD | PMID:37019170 | cisplatin | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of GARNL3 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GARNL3 mRNA | CTD | PMID:27392435 | diarsenic trioxide | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GARNL3 mRNA | CTD | PMID:20458559 | diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of GARNL3 mRNA | CTD | PMID:29108742 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GARNL3 mRNA | CTD | PMID:32289291 | ethylparaben | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of GARNL3 mRNA | CTD | PMID:37690743 | fulvestrant | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GARNL3 gene | CTD | PMID:31601247 | glyphosate | affects methylation | EXP | | 6480464 | Glyphosate affects the methylation of GARNL3 gene | CTD | PMID:35440735 | hydrogen peroxide | affects expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of GARNL3 mRNA | CTD | PMID:20044591 | inulin | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GARNL3 mRNA | CTD | PMID:36331819 | lead(0) | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Lead results in decreased expression of GARNL3 mRNA | CTD | PMID:19921347 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of GARNL3 gene | CTD | PMID:35440735 | nickel atom | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Nickel results in decreased expression of GARNL3 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GARNL3 mRNA more ... | CTD | PMID:32699268 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of GARNL3 mRNA | CTD | PMID:32680482 | PCB138 | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | pentanal | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | pentanal results in decreased expression of GARNL3 mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Garnl3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GARNL3 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GARNL3 mRNA | CTD | PMID:36331819 | pirinixic acid | multiple interactions | ISO | GARNL3 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GARNL3 mRNA | CTD | PMID:19710929 | propanal | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of GARNL3 mRNA | CTD | PMID:26079696 | silicon dioxide | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of GARNL3 mRNA | CTD | PMID:25895662 | sunitinib | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of GARNL3 mRNA | CTD | PMID:31533062 | temozolomide | affects response to substance | ISO | GARNL3 (Homo sapiens) | 6480464 | GARNL3 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of GARNL3 mRNA | CTD | PMID:31150632 | titanium dioxide | increases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | titanium dioxide results in increased expression of GARNL3 mRNA | CTD | PMID:34973136 | trichostatin A | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of GARNL3 mRNA | CTD | PMID:24935251 | trimellitic anhydride | decreases expression | ISO | Garnl3 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of GARNL3 mRNA | CTD | PMID:19042947 | urethane | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Urethane results in decreased expression of GARNL3 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GARNL3 mRNA | CTD | PMID:24935251 | vorinostat | decreases expression | ISO | GARNL3 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of GARNL3 mRNA | CTD | PMID:27188386 | |